| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PEPTIDES.2010.07.026 |
| P698 | PubMed publication ID | 20699109 |
| P2093 | author name string | Juan Li | |
| Chun Hui Liu | |||
| Feng Shan Wang | |||
| P2860 | cites work | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| Thymosin alpha1: a historical overview | Q28306139 | ||
| History of the discovery of the thymosins | Q28307864 | ||
| Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. | Q31140382 | ||
| Evaluation of efficacy of thymosin alpha1 in the treatment of sepsis: a systematic review | Q33399635 | ||
| Potential Role of Thymosin-alpha1 Adjuvant Therapy for Glioblastoma | Q33606685 | ||
| Cellular immune responses to HIV. | Q34223069 | ||
| Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway | Q34360330 | ||
| Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production | Q34371501 | ||
| Cloning and nucleotide sequencing of the genes rimI and rimJ which encode enzymes acetylating ribosomal proteins S18 and S5 of Escherichia coli K12. | Q34553172 | ||
| Thymosin alpha 1: from bench to bedside | Q34643499 | ||
| Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide | Q34674378 | ||
| Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells | Q34806635 | ||
| Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. | Q35177560 | ||
| Thymosins: chemistry and biological properties in health and disease | Q35753541 | ||
| Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes | Q36003011 | ||
| Roles of thymosins in cancers and other organ systems | Q36038461 | ||
| The peptide molecular links between the central nervous and the immune systems. | Q36214181 | ||
| Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level | Q46967712 | ||
| Construction and application of a yeast expression system for thymosin alpha1. | Q46980635 | ||
| Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice | Q47230335 | ||
| Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene | Q48411482 | ||
| Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C. | Q50571453 | ||
| Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli. | Q51539604 | ||
| Thymosin alpha1 as a chemopreventive agent in lung and breast cancer. | Q51750277 | ||
| Immunopharmacology of thymosin alpha1 and cytokine synergy. | Q53568419 | ||
| Solid-phase synthesis of thymosin alpha 1 using tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin. | Q54543459 | ||
| Thymosin 1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance | Q58855391 | ||
| From lab to bedside: emerging clinical applications of thymosin α1 | Q61160529 | ||
| Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes | Q68708462 | ||
| A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer | Q70113575 | ||
| Automated solid phase synthesis of thymosin alpha 1 | Q71142800 | ||
| Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects | Q72422185 | ||
| Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing | Q74463532 | ||
| Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation | Q79715606 | ||
| [A clinical study of thymosin alpha1 as an auxiliary in treating spontaneous peritonitis in patients with liver cirrhosis] | Q80095979 | ||
| Liposomal plasmid DNA encoding human thymosin alpha and interferon omega potently inhibits liver tumor growth in ICR mice | Q80157904 | ||
| Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1 | Q80475450 | ||
| [Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity] | Q81064301 | ||
| Thymosin alpha1: a promising molecule for important clinical applications | Q83777646 | ||
| Thymalfasin for the treatment of chronic hepatitis C infection | Q36322104 | ||
| Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin) | Q36381898 | ||
| Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems | Q36514863 | ||
| Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer | Q36772403 | ||
| Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance | Q36818200 | ||
| Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis | Q37218889 | ||
| A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma | Q37356797 | ||
| Thymic involution and immune reconstitution. | Q37361275 | ||
| Production of recombinant proteins by microbes and higher organisms | Q37509309 | ||
| Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study | Q38501403 | ||
| Suppression of a cold-sensitive mutation in ribosomal protein S5 reveals a role for RimJ in ribosome biogenesis | Q39597324 | ||
| Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels. | Q39851472 | ||
| Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits | Q40054459 | ||
| The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus | Q40204323 | ||
| Expression and analysis of thymosin alpha1 concatemer in Escherichia coli | Q40210028 | ||
| Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells | Q40235827 | ||
| Purification and properties of bovine thymosin | Q40319653 | ||
| Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment. | Q40455639 | ||
| Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome | Q40555725 | ||
| T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides | Q40734718 | ||
| Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level | Q40890526 | ||
| Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro | Q41053105 | ||
| Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma | Q41170034 | ||
| Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B. | Q42590869 | ||
| A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C. | Q42979415 | ||
| Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial | Q42982620 | ||
| Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders | Q42983344 | ||
| Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor | Q43090553 | ||
| Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris | Q43118529 | ||
| Optimized Fmoc solid-phase synthesis of Thymosin alpha1 by side-chain anchoring onto a PEG resin | Q43267292 | ||
| Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. | Q43853516 | ||
| Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats | Q44041777 | ||
| Thymosin alpha-1 modulates excitatory synaptic transmission in cultured hippocampal neurons in rats | Q44583608 | ||
| A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy | Q44665386 | ||
| Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling | Q44776004 | ||
| Induction of immune responses to a human immunodeficiency virus type 1 epitope by novel chimeric influenza viruses. | Q45207937 | ||
| Overexpression of soluble human thymosin alpha 1 in Escherichia coli | Q45247121 | ||
| Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection | Q45783241 | ||
| [High expression of thymosin alpha 1 by injecting recombinant PVX vector into the tomato fruit]. | Q45917761 | ||
| The rapidly expanding therapeutic role of thymosin alpha-1 in the management of gastrointestinal and systemic infectious disorders. | Q46001736 | ||
| Intraperitoneal co-administration of thymosin alpha-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice | Q46054423 | ||
| RimJ is responsible for N(alpha)-acetylation of thymosin alpha1 in Escherichia coli | Q46057586 | ||
| A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1. | Q46122546 | ||
| Expression of thymosin alpha1-thymopentin fusion peptide in Pichia pastoris and its characterization | Q46235139 | ||
| Expression and activity analysis of interferonalpha-con and thymosin-alpha1 | Q46330227 | ||
| A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected]. | Q46369277 | ||
| The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial | Q46454512 | ||
| Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats | Q46483116 | ||
| P433 | issue | 11 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 2151-2158 | |
| P577 | publication date | 2010-08-10 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | Thymosin alpha 1: biological activities, applications and genetic engineering production | |
| P478 | volume | 31 |
| Q52649899 | A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma. |
| Q58566649 | Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation |
| Q34300980 | Complexes of an alpha thymosin derivative with ¹⁸⁵/¹⁸⁷Re and (⁹⁹m)Tc: structural analysis and initial biological evaluation. |
| Q47200918 | Design of a substrate-tailored peptiligase variant for the efficient synthesis of thymosin-α1. |
| Q47594117 | Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide. |
| Q39014494 | Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study. |
| Q95281797 | Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo |
| Q38747732 | Peptide-Based and Polypeptide-Based Gene Delivery Systems |
| Q38891837 | Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis. |
| Q24186837 | Pharmacological treatments for acute hepatitis B infection: a network meta-analysis |
| Q24186878 | Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis |
| Q58694411 | Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling |
Search more.